Stromal reaction is important for the growth of cancer both in primary and metastatic sites. To demonstrate this reaction during the hepatic metastasis of human colon carcinoma, we histologically investigated alterations to the distribution and phenotype of hepatic stellate cells (HSCs), the only mesenchymal cells in the liver parenchyma, using a nude mouse model. Intrasplenically injected colon carcinoma LM-H3 cells migrated into the space of Disse and underwent proliferation, in close association with hepatocytes and HSCs, at 2 days. At 14 days, HSCs were accumulated around the tumor mass and expressed α α α α-smooth muscle actin, a marker for HSC activation. 
In human colon carcinoma, hepatic metastasis implies a poor prognosis. This event involves several steps, i.e., exfoliation of cancer cells from the primary site, entry into the portal venous system, adhesion to the endothelium and subsequent extravasation in the hepatic microvasculature, and multiplication and formation of glandular or acinar structure in the liver parenchyma. Whether or not colon cancer cells successfully metastasize to the liver depends not only on their cytological properties, such as the cellcoat composition, but also on the hepatic microenvironment involving macrophages 1) and natural killer cells, 2, 3) which constitute the defense system of the liver, and hepatic mesenchymal cells, which may support the growth of cancer cells. In general, metastasized tumor cells modify the supporting mesenchymal tissue in which they grow. This phenomenon, termed stromal reaction, includes activation of fibroblasts or myofibroblastic transformation, 4, 5) enhanced secretion of matrix proteins 6, 7) and neovascularization, 8) all of which promote proliferation and invasion of cancer cells. 9) Myofibroblasts are usually associated with cancers of epithelial origin and contribute to the growth of metastatic tumors before neovascularization is induced. 10) Stromal reaction takes place in colorectal carcinoma both in primary and metastatic sites; for example, stromal fibroblasts express activation markers such as α-smooth muscle actin (αSMA) 11) and F19-antigen (or fibroblast activating protein-α) 12) in association with tumor progression, and tumor-associated myofibroblasts enhance tumor invasiveness. 13) In the liver, hepatic stellate cells (HSCs) are the only mesenchymal cells present in the extravascular space of the liver parenchyma. While quiescent in the steady state, they are activated by various stimuli and undergo transformation into myofibroblasts, which are characterized by expression of αSMA, 14) acquisition of contractility, 15) enhanced secretion of growth factors such as transforming growth factor-β (TGF-β), 16) platelet-derived growth factor (PDGF) 17, 18) and hepatocyte growth factor (HGF), 19) and an increased production of extracellular matrix materials. 20, 21) Activated HSCs or transformed myofibroblasts also express receptors for PDGF-β 22) and TGF-β. 23) Recent in vitro studies have demonstrated that hepatic myofibroblasts promote the proliferation of hepatocellular carcinoma (HCC) cell lines, and the latter cells in turn activate and promote proliferation of the former cells. 24, 25) Similarly, hepatic metastasis of murine melanoma cells induces activation and proliferation of HSCs in vivo and induces them to release matrix metalloproteinase-2 and an unknown tumor-chemotactic factor, suggesting that tumorinduced HSC activation may contribute to the progression of hepatic metastasis. 26) There have been, however, no in vivo or in vitro studies on the interaction between HSCs and colon carcinoma cells.
We previously established a human colon carcinoma cell line LM-H3 which acquired a high metastatic capacity due to increased sialyl Lewis A expression and fucosyltransferase activity, and we developed a nude mouse model in which hepatic metastasis of human colon carcinoma can be experimentally analyzed. 27) In this study, to reveal the bidirectional interactions between human colon carcinoma cells and HSCs, we firstly demonstrated accumulation and activation of HSCs around hepatic metastasis of human colon carcinoma cells, and then investigated in the culture the growth factors involved in the enhanced proliferation and migration of activated HSCs and colon carcinoma cells.
MATERIALS AND METHODS

Animals
Female BALB/c nude mice (4 weeks, Charles River Inc., Atsugi) and male Wistar rats (10-12 weeks, SLC, Shizuoka) were used for in vivo and in vitro studies, respectively. They were housed in specific-pathogen-free conditions and fed standard chow pellets and water ad libitum. Experiments were performed according to the standard guideline for animal experiments of the Osaka City University Medical School. Tumor cells We used a highly metastatic colon carcinoma cell line LM-H3 obtained after three in vivo passages of a human colon cancer cell line OCUC-LM1, which was established from the liver metastasis of moderately differentiated adenocarcinoma of the colon in our laboratory. 27) LM-H3 cells were seeded in 10-cm culture dishes (Falcon, Lincoln Park, NJ) and cultured in 10 ml of Dulbecco's modified Eagle's medium (DMEM; Bioproducts, Walkersville, MD) containing 10% fetal bovine serum (FBS; Gibco, Grand Island, NY), 100 IU/ml penicillin (ICN Biomedicals, Costa Mesa, CA), 100 µg/ml streptomycin (ICN Biomedicals) and 0.5 mM sodium pyruvate (Bioproducts) at 37°C for 5 days until they became semi-confluent on the culture dish. Formation of hepatic metastasis BALB/c nude mice were used. Under ether anesthesia, the abdomen was opened, and 1×10
7 cells/ml LM-H3 cells suspended in 0.1 ml of phosphate-buffered saline (PBS) were injected into the lower pole of the spleen. Splenectomy was conducted at 2-3 min after injection. Histology At 1, 2, 3, 4 and 14 days after tumor cell injection, animals were sacrificed. Three mice were used at each time point. Under ether anesthesia, the liver was perfused via the portal vein first with PBS and then with either 1.5% glutaraldehyde in 0.067 M cacodylate buffer, pH 7.4, plus 1% sucrose or 4% paraformaldehyde in PBS. Glutaraldehyde-or paraformaldehyde-fixed materials were post-fixed in 1% OsO 4 in 0.1 M phosphate buffer, pH 7.4, for 2 h, dehydrated in an ethanol series and embedded in Polybed (Polyscience Inc., Warrington, PA). Semithin sections were stained with toluidine blue and observed light-microscopically. Thin sections were stained with uranyl acetate and lead citrate and observed under a JEM1200EX electron microscope (JEOL, Tokyo) at 100 kV.
Paraformaldehyde-fixed materials were also embedded in OCT compound (Sakura Fine Technical Co., Tokyo) and frozen with liquid nitrogen. Cryosections were cut by a CM3050 cryostat (Leica Instruments GmbH, Nussloch, Germany). After incubation with normal animal serum for 30 min at room temperature, sections were incubated with primary antibodies overnight at 4°C. Primary antibodies used here were rabbit anti-desmin antibody (1:50, Monosan, Uden, Netherlands) and mouse anti-human αSMA monoclonal antibody (1A4, 1:500, DAKO, Carpenteria, CA). The sections were washed with PBS, and treated with 0.3% hydrogen peroxide in methanol to block endogenous peroxidase activity. They were then incubated with biotinylated swine anti-rabbit IgG antibody (1:500, DAKO) or anti-mouse IgG antibody (1:500, DAKO) for 30 min at room temperature, followed by incubation with avidin-biotin peroxidase complex (Vector Laboratories Inc., Peterborough, UK) for 60 min at room temperature. Immunoreactions were visualized by treating sections with 0.2 mg/ml 3,3′-diaminobenzidine tetrahydrochloride (DAB) in 0.05 M Tris-buffered saline, pH 7.4, in the presence of 0.003% hydrogen peroxide for 3-5 min. Counterstaining for nuclei was done with hematoxylin. Isolation and culture of HSCs HSCs were isolated from the rat liver as previously reported. 15) Rats (300-400 g b.w.) were anesthetized with intraperitoneal injection of 0.1-0.2 ml/100 g b.w. pentobarbital. After canulation into the portal vein, the liver was perfused with SC-1 balanced salt solution [8 For culture, HSCs were suspended in DMEM supplemented with 10% FBS (Gibco) and antibiotics (0.035 g/ liter penicillin and 100 mg/liter streptomycin) at the cell density of 5×10 5 cells/ml and cultured in 60-mm plastic dishes (Falcon). They were identified by the typical star-like configuration and vitamin A fluorescence. The purity was always higher than 95%, and the viability was more than 90% as evaluated by a trypan blue exclusion test. Because HSCs are activated at later than 3 days after culture, as represented by PDGFR-β expression, 28) we used 7-day cultured HSCs as activated HSCs for proliferation and migration assays. Preparation of conditioned medium of cell culture At 6 h after seeding freshly isolated HSCs (5×10 5 cells/ml) in DMEM supplemented with 10% FBS, the medium was changed with 2 ml of serum-free DMEM. Serum-free conditioned medium of quiescent HSCs (qHSC-CM) was obtained by subsequent 2-day culture at 37°C. There was no significant decrease in cell viability of HSCs at 2 days compared to that of HSCs cultured with serum-containing DMEM. For the preparation of serum-free conditioned medium of activated HSCs (aHSC-CM), freshly isolated HSCs (5×10 5 cells/ml) were cultured in DMEM supplemented with 10% FBS for 2 days. After washing twice with DMEM, 2 ml of fresh serum-free DMEM was supplied. After a subsequent 5-day culture, aHSC-CM was obtained. Serum-free conditioned medium of cultured LM-H3 cells (LM-H3-CM) was prepared by incubating LM-H3 cells with serum-free DMEM at 37°C for 4 days. Proliferation assay LM-H3 cells (2×10 5 cells/400 µl) or activated HSCs (2.5×10 5 cells/500 µl) were seeded into 24-well microplates (Falcon) and cultured with 400 µl of serum-free aHSC-CM or 500 µl of serum-free LM-H3-CM, respectively, for 3 days. Culture with serum-free DMEM was used as the control. Cells were harvested by 10-min trypsin digestion. Cell numbers were counted by a Coulter counter (Coulter Electronics, Luton, UK). Migration assay Transwell double chambers with an 8-µm pore size (Costar, Cambridge, MA) were used. In the upper chamber were seeded LM-H3 cells (5×10 4 cells/ 100 µl) or activated HSCs (5×10 4 cells/100 µl), while the lower chamber contained 600 µl of serum-free aHSC-CM or 600 µl of serum-free LM-H3-CM, respectively. After 6-h culture at 37°C, cells remaining on the upper surface of filter were completely wiped away with a cotton swab, and the filter was stained with hematoxylin. The number of cells that had migrated to the lower surface of the filter was counted light-microscopically. ELISA analysis of growth factors Growth factors involved in serum-free LM-H3-CM were quantitated by using ELISA kits for human PDGF-AB (Genzyme, Minneapolis, MN), human HGF (Genzyme), human TGF-β (R&D, Mineapolis, MN), human basic fibroblast growth factor (b-FGF; R&D), human epidermal growth factor (EGF; R&D), human interleukin-1-α (IL-1α; Genzyme), human IL-1β (Genzyme) and human tumor necrosis factor-α (TNF-α; R&D), and those in serum-free qHSC-CM and aHSC-CM were quantitated by using ELISA kits for human PDGF-AB (Genzyme) [human PDGF-AB has 95% homology with rat PDGF-AB; because an ELISA kit for PDGF-AA was not commercially available, we used a kit for PDGF-AB], rat HGF (Institute of Immunology, Tokyo), rat TGF-β (Morinaga, Kanagawa), human b-FGF (Genzyme) [human b-FGF has 95.5% homology with rat b-FGF] and rat TNF-α (Genzyme).
Treatments of cell culture with neutralizing antibodies
In in vitro proliferation and migration assays for LM-H3 cells, rabbit anti-human PDGF-AA antibody (final concentration of 4, 40, 200 µg/ml; Genzyme), goat anti-human PDGF-BB antibody (6, 60, 300 ng/ml; Genzyme), goat anti-human HGF antibody (2, 20, 100 µg/ml; Genzyme) and rabbit anti-human TGF-β (1, 10, 50 µg/ml; Genzyme), and goat IgG standard (Chemicon International Inc., Temecula, CA) were added to the LM-H3 cell culture or the lower chamber supplemented with serum-free aHSC-CM. As controls, goat IgG standard (Chemicon International Inc.) or rabbit IgG standard (Cedarlane, Ontario, Canada) was used. In in vitro proliferation and migration assays for activated HSCs, goat anti-rat PDGF-AB (2, 20, 200 µg/ml, Upstate Biotechnology) was added to the HSC culture or the lower chamber in which serumfree LM-H3-CM was supplemented. As a control, goat IgG standard (Chemicon International Inc.) was used. Percent inhibition (%) was calculated as follows. Percent inhibition=(cell number in serum-free aHSC-CM or LM-H3-CM−cell number in serum-free aHSC-CM or LM-H3-CM treated with neutralizing antibodies or IgG standard)/ (cell number in serum-free aHSC-CM or LM-H3-CM− cell number with serum-free DMEM alone)×100. Statistics Data were expressed as the mean±standard deviation (SD). The significance of differences was analyzed by using the unpaired Student's t test.
RESULTS
Histological analysis of spatial association of LM-H3 cells with HSCs during the development of hepatic metastasis At one day after intrasplenic injection, LM-H3 cells were localized in the hepatic sinusoids, adhering to the endothelial cells (Fig. 1A) . At 2 days, they migrated out of the sinusoids, entering the space of Disse (Figs. 1B,  2A ) and making direct contact with HSCs ( Fig. 2A, inset) and hepatocytes ( Fig. 2A) . At 3 days, they proliferated and formed micrometastatic foci preferentially in the periportal zone (Fig. 1C) . Tumor cells were often arranged in a glandular structure, enclosing a lumen (Fig. 1C, 1D ). They deeply invaded the hepatic cell plate and came into close apposition to the hepatocytes (Figs. 1D, 2B) , with desmosomal junctions between them (Fig. 2B, inset) . Due to expansion of the tumor mass, surrounding hepatocytes were considerably attenuated, and consequently, the distance between tumor cells and HSCs in adjacent sinusoids was greatly shortened (Fig. 2B) . At 14 days, tumor masses enclosing a lumen increased in size in the space of Disse, facing the sinusoidal lumen in places (Fig. 1E) . In such portions, HSCs made direct contact with tumor cells and Fig. 1E on hepatocytes. C. Fragments of hepatocellular cytoplasm (double arrows) are interposed between tumor cells (T) and HSCs (S), of which the latter contain lipid droplets (d) and dilated rough endoplasmic reticulum (r). The left one shows condensation of cytoplasm. D. In the portion facing the sinusoidal lumen (asterisks), HSCs (S) with well developed rough endoplasmic reticulum (r) are extended along the tumor mass, making a direct contact with tumor cells (T). There are endothelial cells (E) between HSCs and hepatocytes (H), suggesting sinusoidal obliteration here. A condensed, small cytoplasm of hepatocytes (double arrows) is seen. A, ×3800, inset, ×9500; B, ×4300, inset ×27 000; C, ×4500; D, ×7300.
further extended between tumor cells and hepatocytes together with endothelial cells, representing sinusoidal obliteration due to tumor expansion (Fig. 2D) . Between tumor cells and HSCs were often found small parts of hepatocellular cytoplasm (Fig. 2C) , probably derived from the attenuated cytoplasm shown in Fig. 2B . Accumulation and activation of HSCs around the metastatic foci of LM-H3 cells When the tumor mass increased in size at 14 days, desmin-positive, spindleshaped cells resembling HSCs were distributed more frequently around the metastatic foci than in the normal portion of liver parenchyma (Fig. 3) . Until 4 days, αSMA was expressed exclusively in the perivascular smooth muscle cells of the portal vein and the central vein, and was not detected in the liver parenchyma, including the metastatic foci (Fig. 4, A and B) . At 14 days, αSMA-positive cells were abundant around the metastatic foci (Fig. 4C ). They were lined at the basal aspect of glandular structure, often facing the sinusoidal lumen (Fig. 4D) . enhancing function of activated HSCs on proliferation and migration of LM-H3 cells, the effect of aHSC-CM on cultured LM-H3 cells was analyzed. In proliferation assay, serum-free aHSC-CM significantly increased the number of LM-H3 cells at 3 days compared to serum-free DMEM as a control (Fig. 5A) . In migration assay, supplementation with serum-free aHSC-CM in the lower chamber induced migration of significantly larger numbers of LM-H3 cells at 6 h compared to that with serum-free DMEM (Fig. 5B) . In vitro proliferation and migration of activated HSCs was enhanced by serum-free LM-H3-CM In proliferation assay, serum-free LM-H3-CM significantly increased the number of activated HSCs at 3 days compared to serum-free DMEM (Fig. 6A) . In migration assay, introduction of serum-free LM-H3-CM into the lower chamber induced migration of significantly larger numbers of activated HSCs to the lower chamber at 6 h compared to that with serum-free DMEM (Fig. 6B) .
In vitro proliferation and migration of LM-H3 cells was enhanced by serum-free aHSC-CM To demonstrate the
Contents of growth factors and cytokines in serum-free LM-H3-CM, qHSC-CM and aHSC-CM The contents
of growth factors and cytokines in serum-free LM-H3-CM, qHSC-CM and aHSC-CM were measured by ELISA analysis (Table I) . Serum-free LM-H3-CM contained a large amount of PDGF-AB, but negligible amounts of HGF, TGF-β, EGF, b-FGF, IL-1α and TNF-α. Serum-free qHSC-CM contained HGF but not PDGF-AB or TGF-β, while serum-free aHSC-CM contained large amounts of PDGF-AB, HGF and TGF-β, but not b-FGF, IL-1α or TNF-α. Suppressive effects of anti-growth factor antibodies on in vitro proliferation and migration of LM-H3 cells Treatment with anti-PDGF-AA antibody or with anti-PDGF-BB antibody significantly suppressed aHSC-CMinduced in vitro proliferation of LM-H3 cells, while that with anti-HGF antibody did not (Table II) . Furthermore, treatment with anti-PDGF-BB antibody or with anti-HGF antibody significantly inhibited aHSC-CM-induced in vitro migration of LM-H3 cells, while that with anti-PDGF-AA antibody or with anti-TGF-β antibody did not (Table II) . 
Suppressive effects of anti-growth factor antibodies on in vitro proliferation and migration of activated HSCs
Because only PDGF-AB was detected in LM-H3-CM among the growth factors and cytokines examined here (Table I) , we investigated the suppressive effect of a neutralizing antibody against PDGF-AB (we used this antibody because a neutralizing antibody against rat PDGF-BB was not commercially available). Treatment with anti-PDGF-AB antibody significantly inhibited LM-H3-CMinduced in vitro proliferation and migration of activated HSCs (Table III) .
Expression of PDGFR-α α α α, PDGFR-β β β β and c-met in LM-H3 cells To reveal the expression of PDGFR-α, PDGFR-β and c-met in LM-H3 cells, flow cytometric analysis was conducted. The proportions of positive cells for PDGFR-α, PDGFR-β and c-met were 56.2%, 54.9% and 59.5%, respectively (Fig. 7) .
DISCUSSION
The present study using a nude mouse model 27) demonstrated that human colon carcinoma cells which metasta- 29) demonstrated using murine and human colon carcinoma cell lines that a hepatocyte-derived growth factor different from PDGF and FGF had a tumor-growth-promoting activity, suggesting its role in the regulation of selective survival and colonization in the liver. In addition to the close apposition to the hepatocytes, LM-H3 cells retained direct contact with HSCs which surrounded the sinusoid from which tumor masses received their blood supply. As the tumor increased in size, the cytoplasm of the hepatocytes enclosing tumor cells was considerably attenuated and ultimately torn off, thus making nearby HSCs join the peritumoral accumulation of HSCs.
Immunohistochemical study demonstrated that peritumoral HSCs were more frequent than HSCs in the surrounding normal parenchyma, suggesting their local proliferation or migration. Furthermore, while quiescent at days 2-4, they became activated by day 14, as represented by positive staining for αSMA. These results indicate that, in spite of cytological and architectural differences from murine melanoma cells, LM-H3 cells induced similar peritumoral accumulation and activation of HSCs.
Because close association and probable interaction between LM-H3 cells and HSCs were suggested by the present in vivo study, we next investigated the growth factors involved in the interactions between them in vitro. The appropriateness of this in vitro model using human tumor cells and rat HSCs is supported by the high homology of amino acid sequences of PDGF-AA, PDGF-BB, HGF and TGF-β between humans and rats, i.e., 95.7%, 89.0%, 91.6% and 99.1%, resepectively, according to the manufacturers' documentation. Serum-free aHSC-CM, which contained PDGF-AB, HGF and TGF-β, significantly augmented proliferation and migration of LM-H3 cells, and this proliferation was inhibited by neutralizing antibodies against PDGF-AA and PDGF-BB, while migration was inhibited by antibodies against PDGF-BB and HGF, consistent with previous data that binding of PDGF-AA or PDGF-BB with PDGFR-α preferentially induces proliferation, while that of PDGF-BB with PDGFR-β leads to proliferation and migration. 30) These data suggest that PDGF-AA and/or BB and HGF secreted by activated HSCs play important roles in inducing LM-H3 cell proliferation and migration. Responsiveness of LM-H3 cells to these growth factors was supported by their expression of PDGFR-α PDGFR-β and c-met. The present results are also consistent with the previous findings that PDGF-BB promoted the growth of colon cancer cells in vivo, 31) and HGF increased the invasiveness of two HCC cell lines (HepG2 and HuH7) in vitro. 24) In the latter experiment, however, HGF showed opposite effects on proliferation in the two cell lines, and, furthermore, PDGF had no appreciable effect on them, 24) suggesting that responsiveness to growth factors may vary among tumor cell lines or types. In contrast to PDGF and HGF, TGF-β, which inhibits tumor growth early in progression, 32) had no effect on LM-H3 cell migration.
Action of LM-H3 cells directed to activated HSCs was also demonstrated in vitro. Serum-free LM-H3-CM containing PDGF-AB but not HGF and TGF-β induced proliferation and migration of activated HSCs. It is reported that activated HSCs express PDGFR-α and PDGFR-β and undergo proliferation and migration in response to PDGF-AA and PDGF-BB. 18, 28, [33] [34] [35] Taking this into account, the present results suggest that PDGF may be responsible for augmenting the effects of LM-H3-cells on activated HSCs. Nakamura et al. 36) reported that PDGF and interleukin (IL)-1 derived from tumor cells played a role in inducing HGF expression in stromal cells, which in turn led to the invasive growth of carcinoma cells. Because activated HSCs also produce PDGF-AB, which could act on them in an autocrine manner, the functional significance of the paracrine action of LM-H3-cell-derived PDGF-AB on activated HSCs needs to be further investigated.
The mechanism of HSC activation by tumor cells is not well understood. Olaso et al. supposed that quiescent HSC-activating factors might be released from metastatic melanoma cells. 26) Some human and rat colon cancer cell lines are reported to produce TGF-β, 37, 38) which stimulates HSCs to transform into myofibroblast-like cells and enhances their production of extracellular matrix proteins. 20, 39, 40) In this study, LM-H3 cells did not secrete TGF-β, but secreted PDGF-AB instead. An inducing function of PDGF in HSC activation has been reported. 41) Rat HCC cell lines which induced HSC activation, on the other hand, failed to produce PDGF-BB. 25) Therefore, different kinds of growth factors might be involved in HSC activation in different tumors.
In conclusion, there are mutual interactions involving PDGF and HGF between cultured colon carcinoma cells and HSCs, suggesting that similar interactions may be present in the hepatic metastasis of human colon carcinoma. 
